These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8737615)

  • 1. Urinary excretion of relaxin after estradiol treatment of postmenopausal women.
    Lippert TH; Armbruster FP; Seeger H; Mueck AO; Zwirner M; Voelter W
    Clin Exp Obstet Gynecol; 1996; 23(2):65-9. PubMed ID: 8737615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of transdermal versus oral estradiol administration on the excretion of vasoactive markers in postmenopausal women].
    Mueck AO; Seeger H; Lippert TH
    Gynakol Geburtshilfliche Rundsch; 2000; 40(2):61-7. PubMed ID: 10971087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of insulin after estradiol treatment of postmenopausal women.
    Mueck AO; Seeger H; Armbruster FP; Lippert TH
    Clin Exp Obstet Gynecol; 1997; 24(1):11-3. PubMed ID: 9107446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of vasoactive markers following estrogen replacement therapy in postmenopausal women.
    Mueck AO; Seeger H; Lippert C; Wallwiener D
    Int J Clin Pharmacol Ther; 2000 Aug; 38(8):381-6. PubMed ID: 10984011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Am J Cardiol; 1995 Feb; 75(4):264-8. PubMed ID: 7832136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women.
    Cagnacci A; Modena MG; Malmusi S; Muia N; Volpe A
    Am J Cardiol; 1999 Aug; 84(3):367-70, A9-10. PubMed ID: 10496459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
    Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
    Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sequential estrogen/progestin treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal application.
    Seeger H; Mueck AO; Teichmann AT; Lippert TH
    Clin Exp Obstet Gynecol; 2000; 27(1):17-20. PubMed ID: 10758791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
    Lübbert H; Nauert C
    Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin metabolite excretion after postmenopausal estradiol therapy.
    Lippert TH; Filshie M; Mück AO; Seeger H; Zwirner M
    Maturitas; 1996 May; 24(1-2):37-41. PubMed ID: 8794432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of estradiol on urodilatin production in postmenopausal women.
    Seeger H; Armbruster FP; Mueck AO; Lippert TH
    Arch Gynecol Obstet; 1998; 262(1-2):65-8. PubMed ID: 9836002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women.
    Harvey PJ; Picton PE; Su WS; Morris BL; Notarius CF; Floras JS
    Am Heart J; 2005 Feb; 149(2):291-7. PubMed ID: 15846267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary cGMP excretion after hormone replacement therapy in postmenopausal women.
    Mueck AO; Seeger H; Kasspohl-Butz S; Teichmann AT; Lippert TH
    Exp Clin Endocrinol Diabetes; 1996; 104(5):392-5. PubMed ID: 8957275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
    J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women.
    Mueck AO; Seeger H; Kasspohl-Butz S; Teichmann AT; Lippert TH
    Horm Metab Res; 1997 Feb; 29(2):80-3. PubMed ID: 9105905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.